v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024   54,365,785,000      
Beginning balance at Dec. 31, 2024 $ 716,058 $ 5 $ 6,555,416 $ (5,837,557) $ (1,806)
Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise or vesting of equity awards (in shares)   956,627,000      
Release of common shares from escrow related to acquisition 1,237   1,237    
Issuance of common stock in settlement of purchase price holdback 777 $ 1 776    
Stock-based compensation expense 42,678   42,678    
Total other comprehensive (loss) income 3,459       3,459
Net loss (151,257)     (151,257)  
Ending balance (in shares) at Jun. 30, 2025   55,425,334,000      
Ending balance at Jun. 30, 2025 612,952 $ 6 6,600,107 (5,988,814) 1,653
Beginning balance (in shares) at Mar. 31, 2025   54,698,246,000      
Beginning balance at Mar. 31, 2025 647,427 $ 5 6,576,786 (5,928,514) (850)
Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise or vesting of equity awards (in shares)   624,166,000      
Release of common shares from escrow related to acquisition 298   298    
Issuance of common stock in settlement of purchase price holdback (in shares)   102,922,000      
Issuance of common stock in settlement of purchase price holdback 777 $ 1 776    
Stock-based compensation expense 22,247   22,247    
Total other comprehensive (loss) income 2,503       2,503
Net loss (60,300)     (60,300)  
Ending balance (in shares) at Jun. 30, 2025   55,425,334,000      
Ending balance at Jun. 30, 2025 $ 612,952 $ 6 6,600,107 (5,988,814) 1,653
Beginning balance (in shares) at Dec. 31, 2025 58,207,298 58,207,298      
Beginning balance at Dec. 31, 2025 $ 508,590 $ 6 6,657,053 (6,150,320) 1,851
Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise or vesting of equity awards (in shares)   3,705,605      
Issuance of common stock in settlement of purchase price holdback (in shares)   102,922,000      
Issuance of common stock in ATM offering, net of issuance costs (in shares) 1,798,199        
Issuance of common stock in ATM offering, net of issuance costs $ 16,489        
Stock-based compensation expense 25,403   25,403    
Total other comprehensive (loss) income (901)       (901)
Net loss $ (129,297)     (129,297)  
Ending balance (in shares) at Jun. 30, 2026 63,711,102 63,711,102      
Ending balance at Jun. 30, 2026 $ 420,284 $ 6 6,698,945 (6,279,617) 950
Beginning balance (in shares) at Mar. 31, 2026   61,660,788      
Beginning balance at Mar. 31, 2026 $ 443,153 $ 6 6,674,860 (6,232,907) 1,194
Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise or vesting of equity awards (in shares)   252,115      
Issuance of common stock in ATM offering, net of issuance costs (in shares) 1,798,199        
Issuance of common stock in ATM offering, net of issuance costs $ 16,489        
Stock-based compensation expense 7,596   7,596    
Total other comprehensive (loss) income (244)       (244)
Net loss $ (46,710)     (46,710)  
Ending balance (in shares) at Jun. 30, 2026 63,711,102 63,711,102      
Ending balance at Jun. 30, 2026 $ 420,284 $ 6 $ 6,698,945 $ (6,279,617) $ 950